针刺联合替罗非班治疗超时间窗急性缺血性脑卒中临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R255.2;R743.3

基金项目:

国家优势专科建设项目(甘中医药〔2024〕29号);天水市科技支撑项目(2023-SHFZKJK-2961);国家满意工程第五批全国中医临床优秀人才研修项目(国中医药人教函〔2022〕239号)


Clinical Study on Acupuncture Combined with Tirofiban for Hyperacute Ischemic Stroke Beyond the Time Window
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察针刺联合替罗非班治疗超时间窗急性缺血性脑卒中(AIS) 的临床疗效,及其对血小板功能、脑血流状态的影响。方法:纳入2022年5月—2025年6月天水市中医医院急诊科及脑病科收治的60例超时间窗AIS患者,按随机数字表法分为治疗组与对照组各30例。对照组在常规治疗的同时给予静脉输注替罗非班注射液治疗;治疗组在对照组的基础上选取百会、风池、天柱为主穴,曲池、合谷、手足三里、后溪、肩髎、阳陵泉、悬钟、廉泉、照海为配穴进行针刺治疗。疗程均为2周,评价2组临床疗效和安全性,并观察2 组治疗前后卒中量表(NIHSS)、Barthel 指数(MBI) 及Fugel-Meyer (FMA) 量表评分, 以及血小板计数(BPC)、血小板平均体积(MPV)、血小板分布宽度(PDW) 及血小板聚集率(PAR) 及大脑前动脉(ACA)、大脑中动脉(MCA) 及大脑后动脉(PCA) 平均血流速度。结果:治疗组总有效率为83.33%(25/30),对照组为66.67%(20/30),2组比较,差异有统计学意义(P<0.05)。治疗后,2组NIHSS评分均较治疗前降低(P<0.05),MBI、FMA评分均较治疗前升高(P<0.05);且治疗组NIHSS评分低于对照组(P<0.05),MBI、FMA评分均高于对照组(P<0.05)。治疗后,2组PDW、MPV、PAR、BPC水平均较治疗前降低(P<0.05),且治疗组4项指标水平均低于对照组(P<0.05)。治疗后,2组ACA、MCA、PCA平均血流速度均较治疗前升高(P<0.05),且治疗组MCA、PCA、ACA平均血流速度均高于对照组(P<0.05)。治疗期间,治疗组不良反应发生率为10.00%(3/30),对照组为16.67%(5/30),2组比较,差异无统计学意义(P>0.05)。结论:针刺联合替罗非班治疗超时间窗AIS患者疗效显著,可显著改善患者血小板功能及脑血流状态,且安全性较好。

    Abstract:

    Abstract: Objective: To observe the clinical efficacy of acupuncture combined with Tirofiban on patients with hyperacute ischemic stroke beyond the time window, and to explore its effects on platelet function and cerebral blood flow. Methods:A total of 60 patients with hyperacute ischemic stroke beyond the time window who were admitted into the Emergency Department and Neurology Department of Tianshui Hospital of Chinese Medicine from May 2022 to June 2025 were assigned to the treatment group and the control group through the random number table method , with 30 cases in each group. The control group received intravenous infusion of Tirofiban injection in addition to conventional treatment; the treatment group received acupuncture at the main points Baihui (DU 20), Fengchi (GB 20), and Tianzhu (BL 10) and at auxiliary points Quchi (LI 11), Hegu (LI 4), Shousanli (LI 10), Zusanli (ST 36), Houxi (SI 3), Jianliao (SJ 14), Yanglingquan (GB 34), Xuanzhong (GB 39), Lianquan (RN 23), and Zhaohai (KI 6) based on the treatment in the control group. The course of treatment was two weeks. The clinical effects and safety in both groups were evaluated;the scores of National Institute of Health Stroke Scale (NIHSS),Modified Barthel Index (MBI), and Fugl-Meyer Assessment Scale (FMA), blood platelet count (BPC), mean platelet volume (MPV), platelet distribution width (PDW), platelet aggregation rate (PAR), and the mean blood flow velocity of anterior cerebral artery (ACA),middle cerebral artery (MCA),and posterior cerebral artery (PCA) before and after treatment were observed. Results: The total effective rate was 83.33% (25/30) in the treatment group and 66.67%( 20/30) in the control group,the difference being significant( P<0.05). After treatment,the NIHSS scores of the two groups were decreased when compared with those before treatment (P<0.05),and the MBI and FMA scores were increased when compared with those before treatment (P<0.05); the NIHSS score of the treatment group was lower than that of the control group (P<0.05), and the MBI and FMA scores were higher than those of the control group (P<0.05). After treatment,the levels of PDW,MPV,PAR,and BPC in the two groups were decreased when compared with those before treatment (P<0.05),and the levels of the four indexes in the treatment group were lower than those in the control group (P<0.05). After treatment,the mean blood flow velocity of ACA,MCA,and PCA in the two groups were increased when compared with those before treatment (P<0.05),and the mean blood flow velocity of MCA, PCA, and ACA in the treatment group were higher than those in the control group (P<0.05). During treatment, the incidence of adverse reactions was 10.00% (3/30) in the treatment group and 16.67% (5/30) in the control group,with no statistically significant difference between the two groups (P>0.05). Conclusion:The therapy of acupuncture combined with Tirofiban is significantly effective in treating hyperacute ischemic stroke beyond the time window,which can greatly regulate patients' platelet function and cerebral blood flow with great safety.

    参考文献
    相似文献
    引证文献
引用本文

李东峰,王仕宝,牛璐璐,刘喜平,禄浩.针刺联合替罗非班治疗超时间窗急性缺血性脑卒中临床研究[J].新中医,2026,58(16):66-72

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-08-23
  • 出版日期:
文章二维码